Cystic Fibrosis News Today Weekly Digest

Cystic Fibrosis Weekly Update Contents: Compliance Is One of Our Toughest Mental and Physical Battles FDA Approves AzurRx Biopharma Request to Test MS1819-SD in CF Patients with EPI #NACFC2018 — CFF Announces $100 Million ‘Infection Research Initiative’ Compliance Is One of Our Toughest Mental and Physical Battles Oct 22, 2018 09:00 am | Tré LaRosa As much as we resist the idea, cystic fibrosis can become a defining part of identity; a lifestyle that we’re forced without choice to live day in and day out. A choice exists, I presume; we have the choice to take care of ourselves, to take our medications, to do our treatments — but that’s far […] The post Compliance Is One of Our Toughest Mental and Physical Battles appeared first on Cystic Fibrosis News Today. Read More FDA Approves AzurRx Biopharma Request to Test MS1819-SD in CF Patients with EPI Oct 22, 2018 07:00 am | Alice Melão AzurRx BioPharma is planning a multi-center Phase 2 trial to be conducted in the United States and Europe to evaluate its lead candidate MS1819-SD as a treatment for patients with exocrine pancreatic insufficiency (EPI) due to cystic fibrosis (CF). This announcement follows the approval by the U.S. Food and Drug Administration (FDA) of an Investigational […] The post FDA Approves AzurRx Biopharma Request to Test MS1819-SD in CF Patients with EPIappeared first on Cystic Fibrosis News Today. Read More #NACFC2018 — CFF Announces $100 Million ‘Infection Research Initiative’ Oct 19, 2018 11:30 am | Larry Luxner The Cystic Fibrosis Foundation (CFF) will spend $100 million over the next five years to fund research aimed at fighting infections in patients with cystic fibrosis (CF) — a problem that seems destined to grow as patients live longer with the disease. The announcement came during the 32nd Annual North American Cystic Fibrosis Conference (NACFC) now underway […] The post #NACFC2018 — CFF Announces $100 Million ‘Infection Research Initiative’ appeared first on Cystic Fibrosis News Today. Read More   Recent News We Need to Widen Inclusion Criteria for Cystic Fibrosis Clinical Trials Orkambi May Be More Effective in CF Patients with Inflamed Airways, Study Suggests Tips for Keeping a Germ-free Household Hey, CF Caregivers, Your Loving Words Help Us Survive Synspira’s Candidate SNSP113 Wins FDA Orphan Designation to Treat Bacterial Infections in Cystic Fibrosis